FONT-SIZE Plus   Neg

Gardner Denver Q1 Profit Declines; Lowers FY12 EPS Outlook - Quick Facts

Gardner Denver Inc. (GDI) reported that its first-quarter net income attributable to company was $54.8 million or $1.08 per share, compared to $59.5 million or $1.13 per share in the previous year period.

Adjusted earnings per share was $1.40, compared to $1.15 last year. On average, nine analysts polled by Thomson Reuters expected the company to report profit of $1.36 per share. Analysts' estimates typically exclude special items.

Revenues increased 14% to $604.36 million from $531.85 million in the comparable quarter last year, while seven analysts had consensus revenue estimate of $585.59 million for the quarter.

Gardner Denver expects second quarter earnings per share to be in the range of $1.35 to $1.45, and adjusted earnings per share to be in a range of $1.40 to $1.50. Analysts currently expect earnings of $1.51 per share in the second quarter.

The company expects full-year 2012 earnings per share in the range of $5.20 to $5.40 and adjusted earnings to be in a range of $5.60 to $5.80 per share. Analysts now expect full-year 2012 earnings of $5.93 per share.

Earlier, the company had expected full-year 2012 earnings to be in the range of $5.85 to $6.05 per share and adjusted earnings per share in the range of $6.00 to $6.20.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Apple confirmed that it has bought face animation software firm Faceshift, although it was tight lipped about how it intends to use the new addition. The move is speculated as a bid to expand into virtual reality. Environment ministry of South Korea Thursday ordered Volkswagen Korea to recall 125,522 diesel vehicles on determining actual emissions of nitrogen oxides. The ministry has asked the German automobile maker to pay a fine of 14.1 billion Won or $12.31 million. The company has to submit a recall plan by January 6, 2016. The U.S. Food and Drug Administration has alerted health care professionals and patients of a voluntary recall of compounded multivitamin capsules containing high amounts of Vitamin D3 (Cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida. FDA has received reports of several...
comments powered by Disqus
Follow RTT